Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGDIG | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | POFUT2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | C11orf68 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SPNS1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NRXN1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | LMO7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ATP5H | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ARHGAP12 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | TP53BP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AC006386.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |